Watertown, MASSACHUSETTS—(GLOBE NEWSWIRE)—EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a biopharmaceutical company committed to developing and commercializing innovative ophthalmic products today announced the pricing of an underwritten public offering of 15,000,000...
MEMPHIS, Tennessee—Cognate BioServices, a leading contract development and manufacturing organization (CDMO) specialized in cell and cell-mediated gene therapy products today announced that it has completed the acquisition of Cobra Biologics, a leading CDMO...
Leading Dental Technology Company Raises $85 Million to Accelerate Growth LAGUNA HILLS, California—Sonendo, Inc., a leading dental technology company, announced today that EW Healthcare Partners, a global healthcare growth equity firm, led an $85 million financing for...
MALVERN, Pennsylvania—TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today...
MALVERN, Pennsylvania—TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today...
LAGUNA HILLS, California—Inc. magazine today revealed that Sonendo®, developer of the GentleWave® System, is No. 19 on its annual Inc. 5000 list of the nation’s fastest-growing private companies. “It is an honor to be named to this year’s Inc. 5000 list. This...
BALTIMORE & MEMPHIS, Tennessee –(BUSINESS WIRE)–Cognate BioServices, a leading contract development and manufacturing organization (“CDMO”) in the global cellular therapies industry, announced today it has secured a financial sponsor to support its short-term and...
Team of Experienced Healthcare Investors and Former Healthcare Executives Will Invest in Select Healthcare Companies to Seek to Accelerate Their Revenue Growth Partner and Principals Promoted in London, New York and Palo Alto Offices New York, NY –– EW Healthcare...
SAN ANTONIO—(BUSINESS WIRE)—Candida auris (C.auris) is an emerging, often multi-drug resistant, fungus that causes serious and often deadly infections in healthcare settings. The Centers for Disease Control & Prevention (CDC) recently issued a warning about...
